STOCK TITAN

Teladoc (NYSE: TDOC) CAO sells shares to cover RSU tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Teladoc Health Chief Accounting Officer Joseph Ronald Catapano reported routine equity compensation activity and a small related share sale. On April 1, 2026, restricted stock units converted into 2,083 shares of Teladoc common stock on a one-for-one basis at a conversion price of $0.00.

On April 2, 2026, he sold 675 common shares at $5.114 per share solely to cover the tax withholding obligation tied to the RSU vesting, rather than as a discretionary open-market sale. After these transactions, he directly held 10,249 common shares.

The filing notes that on October 1, 2024, he was granted 25,000 restricted stock units, with one-third vesting on the first anniversary of the grant and the remainder vesting in eight substantially equal quarterly installments thereafter.

Positive

  • None.

Negative

  • None.
Insider Catapano Joseph Ronald
Role Chief Accounting Officer
Sold 675 shs ($3K)
Type Security Shares Price Value
Sale Common Stock 675 $5.114 $3K
Exercise Restricted Stock Units 2,083 $0.00 --
Exercise Common Stock 2,083 $0.00 --
Holdings After Transaction: Common Stock — 10,249 shares (Direct); Restricted Stock Units — 12,501 shares (Direct)
Footnotes (1)
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Tax-related share sale 675 shares at $5.114 Common stock sold on April 2, 2026 to cover tax withholding
RSUs converted 2,083 shares at $0.00 Restricted stock units converting one-for-one into common stock on April 1, 2026
Shares held after transactions 10,249 shares Direct Teladoc common stock holdings following April 2026 transactions
RSU grant size 25,000 restricted stock units Granted on October 1, 2024 with staged vesting over time
RSU vesting structure 1/3 then eight quarterly installments One-third vests after one year, remainder in eight substantially equal quarterly installments
Restricted stock units financial
"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligation financial
"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards."
vest financial
"vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
one-for-one basis financial
"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Catapano Joseph Ronald

(Last)(First)(Middle)
C/O TELADOC HEALTH, INC.,
155 E 44TH ST, SUITE 1700

(Street)
NEW YORK NEW YORK 10017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026M2,083A(1)10,924D
Common Stock04/02/2026S675(2)D$5.11410,249D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)04/01/2026M2,083 (3) (3)Common Stock2,083$012,501D
Explanation of Responses:
1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Remarks:
/s/ Adam C. Vandervoort, Attorney-in-Fact04/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Teladoc (TDOC) report for Joseph Ronald Catapano?

Teladoc’s Chief Accounting Officer Joseph Ronald Catapano had 2,083 restricted stock units convert into common stock and sold 675 shares. The sale was specifically to cover tax withholding on the RSU vesting, not a discretionary open-market sale.

How many Teladoc (TDOC) shares did the CAO sell and at what price?

He sold 675 Teladoc common shares at $5.114 per share. According to the filing footnote, this sale was executed solely to satisfy tax withholding obligations arising from the vesting of his restricted stock unit awards.

How many Teladoc (TDOC) shares does the CAO hold after these transactions?

Following the RSU conversion and tax-related sale, Joseph Ronald Catapano directly holds 10,249 Teladoc common shares. This figure reflects his position after the 2,083-share RSU conversion and the subsequent 675-share sale to cover tax withholding.

What restricted stock unit grant does the Teladoc (TDOC) CAO have outstanding?

He was granted 25,000 restricted stock units on October 1, 2024. One-third of this award vests on the first anniversary of the grant date, with the remaining units vesting in eight substantially equal quarterly installments thereafter, subject to continued service conditions.

How do the Teladoc (TDOC) RSUs convert into common stock for the CAO?

The restricted stock units convert into Teladoc common stock on a one-for-one basis. In this filing, 2,083 RSUs converted into 2,083 common shares at a stated conversion price of $0.00 per share, reflecting non-cash equity compensation.

Was the Teladoc (TDOC) CAO’s share sale a typical open-market disposition?

Although coded as a sale, the filing explains the 675-share disposition was to cover tax withholding obligations on vested RSUs. This indicates a tax-related, mechanical transaction rather than a discretionary open-market sale driven by a change in outlook.